This Is Too Hot For Trevena Inc. (NASDAQ: TRVN), Let’s Take A Closer Look

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Trevena Inc. (TRVN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by +$0.0044, or +1.87%, to $0.2394. Volume reached 41,634 shares, with price reaching a high of $0.24 and a low of $0.229. Most recently, Yahoo Finance reported about the stock as it publicized that Trevena, Inc. Announces Closing of Registered Direct Offering of Preferred Stock.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Stocks Info

As a NASDAQ listed company, TRVN falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $0.23 and fluctuated between $0.2400 as its day high and $0.2099 as its day low. The current market capitalization of Trevena Inc. is $41.12M. A total of 2.21 million shares were traded on the day, compared to an average of 2.04M shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, TRVN has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 31,785 shares. Over the last 12 months, there were 7 BUYs and 9 SELLs from insiders. Insiders purchased 2,612,500 shares during that period but sold 283,186.

In the most recent transaction, Shin Barry sold 31,785 shares of TRVN for 0.41 per share on Jun 28. After the transaction, the SVP, CFO now owns 873,056 company shares.


Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for TRVN in the last 3 months, the mean price target is $3.17 with high estimates of $4.00 and low estimates of $2.00. In terms of 52-week highs and lows, TRVN has a high of $1.54 and a low of $0.18.

As of this writing, TRVN has an earnings estimate of $-0.11 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of $-0.1 per share and a lower estimate of $-0.11. The company reported an EPS of $-0.1 in the last quarter, which was -11.11% lower than expectations of $-0.09.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 4 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TRVN is Buy with a score of 4.33. A total of 3 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.